Skip to content

Recall watch for the stuff you own · As an Amazon Associate we earn from qualifying purchases · Some links earn a commissionDisclosure

ConsumerSun

FDAFDA recall D-0831-2026 · Sep 2, 2026

Hikma Pharmaceuticals USA INC.: Ramipril Capsules USP recall

Quick answer

Product
Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228.
Brand
Hikma Pharmaceuticals USA INC.
Codes, lots and dates
a) Lot #: AC5470A, Exp. Date July 2027 b) Lot #: AC5470B, Exp. Date July 2027
Hazard
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
Distribution
Nationwide within the United States
Quantity
a) 25,970 bottles; b) 2,384 bottles
Recall date
Sep 2, 2026
Agency
U.S. Food and Drug Administration (FDA) enforcement report
Recall number
D-0831-2026

Recall found

Product

Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228.

Reason for recall

Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

What to do

FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.

Recall facts
Quantitya) 25,970 bottles; b) 2,384 bottles
Codes, lots and datesa) Lot #: AC5470A, Exp. Date July 2027 b) Lot #: AC5470B, Exp. Date July 2027
DistributionNationwide within the United States
Recall dateSep 2, 2026
ClassClass II
Agency IDD-0831-2026
Official noticeU.S. Food and Drug Administration (FDA) enforcement report
Data as of, last checkedNov 21, 2026, 3:48 PM EST

Recall details

FDA classification
Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Status
Ongoing
Codes, lots and dates
a) Lot #: AC5470A, Exp. Date July 2027 b) Lot #: AC5470B, Exp. Date July 2027
Quantity
a) 25,970 bottles; b) 2,384 bottles
Distribution
Nationwide within the United States
Recalling firm
Hikma Pharmaceuticals USA INC., Columbus, OH
Voluntary or mandated
Voluntary: Firm initiated
Recall started
2026-08-24

Source: openFDA enforcement record D-0831-2026 · search recall number D-0831-2026 in FDA's Enforcement Report.

Copied from the agency record without changes. Data as of Nov 21, 2026, 3:48 PM EST. The agency notice is the final word.

FAQ

What was recalled?

Product: Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228. Brand: Hikma Pharmaceuticals USA INC. Codes, lots and dates: a) Lot #: AC5470A, Exp. Date July 2027 b) Lot #: AC5470B, Exp. Date July 2027

What is the hazard?

Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

How do I check if mine is affected?

Codes, lots and dates: a) Lot #: AC5470A, Exp. Date July 2027 b) Lot #: AC5470B, Exp. Date July 2027

Where was it distributed?

Nationwide within the United States

Related recalls

Watch my items

Get an email when new recalls are posted for the kinds of things you own. Just your first name and email, nothing else.

Unsubscribe any time with one click. We never share your address.